| 1 | TREM2 levels | GCST90470960 | 78.95 |
| 2 | ALB levels | GCST90497108 | 70.53 |
| 3 | CD83/TREM2 ratio | GCST90313908 | 66.50 |
| 4 | ADGRE2/B4GALT1 ratio | GCST90313174 | 66.14 |
| 5 | Recent trouble relaxing | Anxiety | UKBB00000745 | 65.68 |
| 6 | Urine andro steroid monosulfate C19H28O6S (1)* levels in chronic kidney disease | GCST90264796 | 64.57 |
| 7 | MELTF levels | GCST90469885 | 63.59 |
| 8 | CPVL levels | GCST90468848 | 61.74 |
| 9 | PIK3IP1/TNFRSF1A ratio | GCST90315653 | 59.99 |
| 10 | ALB levels | GCST90497101 | 57.90 |
| 11 | CDCP1/MSR1 ratio | GCST90313938 | 55.88 |
| 12 | ITGA5 levels | GCST90469635 | 54.41 |
| 13 | ALB levels | GCST90475103 | 54.00 |
| 14 | ADGRE2/IFNGR1 ratio | GCST90313177 | 53.47 |
| 15 | IGSF21 levels | GCST90469538 | 52.95 |
| 16 | ADA2/VCAM1 ratio | GCST90313167 | 52.19 |
| 17 | Aspartate aminotransferase levels (UKB data field 30650) | GCST90468063 | 51.95 |
| 18 | PSRC1/SORT1 ratio | GCST90315742 | 51.92 |
| 19 | CD83/HAVCR2 ratio | GCST90313904 | 51.74 |
| 20 | ALB levels | GCST90475106 | 51.12 |
| 21 | Recent inability to stop or control worrying | Anxiety | UKBB00000742 | 50.95 |
| 22 | Aspartate aminotransferase (AST, minimum, inv-norm transformed) | GCST90475124 | 50.72 |
| 23 | Urine 16a-hydroxy DHEA 3-sulfate levels in chronic kidney disease | GCST90264329 | 50.02 |
| 24 | Triacylglycerol (52:4) [NL-16:0] levels | GCST90025170 | 49.41 |
| 25 | Aspartate aminotransferase | Blood biochemistry | UKBB00000052 | 49.20 |
| 26 | HMOX1 levels | GCST90469465 | 48.85 |
| 27 | AXL/MSR1 ratio | GCST90313422 | 48.79 |
| 28 | ALB levels | GCST90475100 | 48.40 |
| 29 | PTPRZ1 levels | GCST90470388 | 46.32 |
| 30 | CCL27 levels | GCST90468579 | 46.21 |
| 31 | MARCO levels | GCST90469861 | 45.94 |
| 32 | Cholesteryl esters to total lipids ratio in large LDL | GCST90092859 | 45.92 |
| 33 | HDL cholesterol levels | GCST90497340 | 45.79 |
| 34 | CD300C/FOLR2 ratio | GCST90313787 | 45.12 |
| 35 | ALB levels | UKBB00000019 | 45.12 |
| 36 | ADGRE2/CD58 ratio | GCST90313175 | 45.05 |
| 37 | CAMKK1/FOXO1 ratio | GCST90313613 | 45.00 |
| 38 | Phospholipids in large LDL | GCST90498049 | 44.74 |
| 39 | GOT1 levels | GCST90469379 | 44.61 |
| 40 | Phospholipids in very large HDL | GCST90500451 | 44.33 |
| 41 | Total concentration of lipoprotein particles | GCST90500103 | 44.04 |
| 42 | HPCAL1/PMVK ratio | GCST90315076 | 43.50 |
| 43 | CTSL levels | GCST90468914 | 43.48 |
| 44 | CD164/LGMN ratio | GCST90313741 | 43.37 |
| 45 | ADGRE5/GAS6 ratio | GCST90313179 | 43.21 |
| 46 | Concentration of HDL particles | GCST90497406 | 43.05 |
| 47 | Triglyceride to HDL cholesterol ratio | GCST90295950 | 43.00 |
| 48 | CD1C levels | GCST90468604 | 42.86 |
| 49 | CRHBP/TREM2 ratio | GCST90314260 | 42.36 |
| 50 | CD74/JAM2 ratio | GCST90313893 | 42.28 |
| 51 | Plasma methylsuccinoylcarnitine levels in chronic kidney disease | GCST90265508 | 41.56 |
| 52 | Cholesteryl Esters in Large LDL | GCST90497949 | 41.48 |
| 53 | Total Lipids in HDL | GCST90497401 | 41.44 |
| 54 | Triglycerides in small HDL | GCST90499516 | 40.99 |
| 55 | CD300C/HAVCR2 ratio | GCST90313789 | 40.74 |
| 56 | LTBP2/PDGFRA ratio | GCST90315338 | 40.70 |
| 57 | Free Cholesterol to Total Lipids in Medium HDL percentage | GCST90498583 | 40.68 |
| 58 | APOA1 levels | GCST90497119 | 40.62 |
| 59 | Cholesteryl Esters in HDL | GCST90497357 | 40.58 |
| 60 | CDCP1 levels | GCST90468667 | 40.49 |
| 61 | MRC1 levels | GCST90469939 | 40.48 |
| 62 | NRP2 levels | GCST90470086 | 40.37 |
| 63 | Cholesteryl Esters to Total Lipids in Medium HDL percentage | GCST90498550 | 40.23 |
| 64 | HDL cholesterol | GCST90018736 | 40.07 |
| 65 | FGA levels | GCST90469216 | 39.91 |
| 66 | ALB levels | GCST90269576 | 39.89 |
| 67 | Cholesterol to Total Lipids in Small HDL percentage | GCST90499369 | 39.85 |
| 68 | Phospholipids to Total Lipids in Large HDL percentage | GCST90497868 | 39.81 |
| 69 | Free Cholesterol in HDL | GCST90497379 | 39.79 |
| 70 | MMP9/PLTP ratio | GCST90315471 | 39.78 |
| 71 | Concentration of large HDL particles | GCST90497836 | 39.77 |
| 72 | IL27 levels | GCST90012017 | 39.75 |
| 73 | Aspartate aminotransferase (AST, mean, inv-norm transformed) | GCST90475121 | 39.74 |
| 74 | HAVCR2/TREM2 ratio | GCST90315031 | 39.61 |
| 75 | Haematocrit percentage (UKB data field 30030) | GCST90468073 | 39.52 |
| 76 | COMP/ITGAV ratio | GCST90314190 | 39.33 |
| 77 | Cholesteryl Esters to Total Lipids in Small HDL percentage | GCST90499403 | 39.28 |
| 78 | MFGE8 levels | GCST90469900 | 39.26 |
| 79 | Total lipids in large HDL | GCST90497818 | 39.23 |
| 80 | CCN2/MGLL ratio | GCST90313714 | 39.18 |
| 81 | Average diameter for HDL particles | GCST90497446 | 39.16 |
| 82 | Total concentration of lipoprotein particles | GCST90500101 | 39.14 |
| 83 | Cholesterol to Total Lipids in Medium HDL percentage | GCST90498519 | 39.02 |
| 84 | PLAUR/TREM2 ratio | GCST90315676 | 39.00 |
| 85 | CTSS levels | GCST90468916 | 38.91 |
| 86 | Triglyceride levels in chylomicrons and extremely large VLDL | GCST90501068 | 38.67 |
| 87 | CD300C/LRRC25 ratio | GCST90313790 | 38.60 |
| 88 | Concentration of HDL particles | GCST90497414 | 38.56 |
| 89 | Phospholipids in HDL | GCST90497430 | 38.51 |
| 90 | NCAM1 levels | GCST90470003 | 38.46 |
| 91 | PLA2G15/PRCP ratio | GCST90315661 | 38.39 |
| 92 | ALB levels | GCST90092807 | 38.36 |
| 93 | ALB levels | GCST90025992 | 38.28 |
| 94 | HDL cholesterol levels | GCST90497352 | 38.03 |
| 95 | PIK3IP1/TNFRSF1B ratio | GCST90315654 | 37.94 |
| 96 | Concentration of medium HDL particles | GCST90498617 | 37.66 |
| 97 | Triglycerides in medium HDL | GCST90498672 | 37.65 |
| 98 | Free Cholesterol in HDL | GCST90497381 | 37.54 |
| 99 | CSPG4 levels | GCST90468890 | 37.53 |
| 100 | Free Cholesterol to Total Lipids in Small HDL percentage | GCST90499431 | 37.36 |
| 101 | Total cholines levels | GCST90497183 | 37.36 |
| 102 | GAS6/NOTCH1 ratio | GCST90314918 | 37.28 |
| 103 | PECAM1/SOD2 ratio | GCST90315647 | 37.23 |
| 104 | LILRA5 levels | GCST90469774 | 37.08 |
| 105 | C1QA levels | GCST90468485 | 36.97 |
| 106 | Cholesteryl Esters to Total Lipids in Large HDL percentage | GCST90497768 | 36.93 |
| 107 | Free Cholesterol to Total Lipids in Medium HDL percentage | GCST90498580 | 36.90 |
| 108 | CCL22 levels | GCST90468574 | 36.88 |
| 109 | COLEC12/TNFRSF1A ratio | GCST90314187 | 36.87 |
| 110 | APOA1 levels | GCST90497122 | 36.76 |
| 111 | High density lipoprotein cholesterol levels | GCST90239651 | 36.69 |
| 112 | RHOC/TBCC ratio | GCST90315775 | 36.53 |
| 113 | Concentration of small HDL particles | GCST90499461 | 36.46 |
| 114 | Aspartate aminotransferase (AST, maximum, inv-norm transformed) | GCST90475118 | 36.44 |
| 115 | Neutrophill count (UKB data field 30140) | GCST90468092 | 36.43 |
| 116 | Neutrophil count | GCST90002351 | 36.41 |
| 117 | NPTX2 levels | GCST90470079 | 36.34 |
| 118 | FCAR/LY96 ratio | GCST90314788 | 36.28 |
| 119 | CD99/RELT ratio | GCST90313930 | 36.24 |
| 120 | Cholesteryl Esters in HDL | GCST90497368 | 36.18 |
| 121 | Phosphatidylcholine levels | GCST90499248 | 36.15 |
| 122 | IGDCC4 levels | GCST90469523 | 36.07 |
| 123 | APOA levels | GCST90468061 | 35.99 |
| 124 | Free cholesterol in very large HDL | GCST90500383 | 35.97 |
| 125 | CD300E/LILRA5 ratio | GCST90313798 | 35.84 |
| 126 | CD40LG/EREG ratio | GCST90313820 | 35.83 |
| 127 | Total phospholipid levels in lipoprotein particles | GCST90500124 | 35.72 |
| 128 | CCL11/CCL7 ratio | GCST90313673 | 35.64 |
| 129 | DPP4 levels | GCST90469033 | 35.50 |
| 130 | Cholesterol to Total Lipids in Large HDL percentage | GCST90497732 | 35.40 |
| 131 | GPNMB levels | GCST90469393 | 35.29 |
| 132 | Neutrophil count | GCST90002398 | 35.26 |
| 133 | ITGA5/VCAM1 ratio | GCST90315206 | 35.11 |
| 134 | ALCAM/ENPP2 ratio | GCST90313236 | 35.09 |
| 135 | Triglycerides in large HDL | GCST90497882 | 35.08 |
| 136 | Triglyceride to phosphoglyceride ratio | GCST90499992 | 34.92 |
| 137 | Other ulcerative colitis | FING00001117 | 34.83 |
| 138 | CES2 levels | GCST90468719 | 34.82 |
| 139 | Cholesteryl Esters in Medium HDL | GCST90498532 | 34.79 |
| 140 | FOLR2/THY1 ratio | GCST90314867 | 34.75 |
| 141 | Free Cholesterol to Total Lipids in Small HDL percentage | GCST90499436 | 34.75 |
| 142 | AXL/CD163 ratio | GCST90313418 | 34.75 |
| 143 | Sleep duration | GCST003839 | 34.73 |
| 144 | MANF/NCK2 ratio | GCST90315359 | 34.70 |
| 145 | Cholesterol in Medium HDL | GCST90498492 | 34.57 |
| 146 | CD83/LAMP3 ratio | GCST90313906 | 34.43 |
| 147 | Concentration of large HDL particles | GCST90497828 | 34.41 |
| 148 | Sum basophil neutrophil counts | GCST004620 | 34.34 |
| 149 | MMP9/OSM ratio | GCST90315468 | 34.33 |
| 150 | Blood cell traits latent factor 7 (white cell) | GCST90559249 | 34.27 |
| 151 | Neutrophil count | GCST004629 | 34.24 |
| 152 | CD300E/CD59 ratio | GCST90313794 | 34.22 |
| 153 | monocyte (fraction, mean, inv-norm transformed) | GCST90475511 | 34.19 |
| 154 | ALCAM/LRRC25 ratio | GCST90313239 | 34.17 |
| 155 | TIMD4 levels | GCST90470866 | 34.13 |
| 156 | MMP9/OLR1 ratio | GCST90315467 | 33.92 |
| 157 | PLTP levels | GCST90470262 | 33.79 |
| 158 | Phospholipids in IDL | GCST90497628 | 33.65 |
| 159 | FOLR3 levels | GCST90469261 | 33.64 |
| 160 | Radial styloid tenosynovitis [de Quervain] | FING00001237 | 33.62 |
| 161 | CD74/TIMD4 ratio | GCST90313896 | 33.60 |
| 162 | PLXNA4/SKAP2 ratio | GCST90315685 | 33.58 |
| 163 | Free cholesterol in small HDL | GCST90499425 | 33.53 |
| 164 | Average diameter for HDL particles | GCST90092828 | 33.53 |
| 165 | FOLR2/HAVCR2 ratio | GCST90314865 | 33.41 |
| 166 | Total lipids in large HDL | GCST90497815 | 33.34 |
| 167 | ADA2/COMP ratio | GCST90313166 | 33.31 |
| 168 | B3GNT7 levels | GCST90468411 | 33.28 |
| 169 | CA6/DNER ratio | GCST90313594 | 33.28 |
| 170 | CD69/SNAP29 ratio | GCST90313887 | 33.23 |
| 171 | FN1 levels | GCST90469255 | 33.18 |
| 172 | Granulocyte count | GCST004614 | 33.17 |
| 173 | LAT/SPARC ratio | GCST90315288 | 33.16 |
| 174 | Phospholipids to total lipids in small LDL percentage (UKB data field 23624) | GCST90269721 | 33.15 |
| 175 | Phosphoglycerides levels | GCST90499265 | 33.13 |
| 176 | CD83 levels | GCST90468652 | 33.12 |
| 177 | Total Lipids in HDL | GCST90497393 | 33.05 |
| 178 | Monounsaturated fatty acid levels | GCST90502038 | 33.04 |
| 179 | NELL2 levels | GCST90470027 | 33.01 |
| 180 | ITGAM levels | GCST90469638 | 33.01 |
| 181 | UFC1 levels | GCST90243245 | 32.99 |
| 182 | NOMO1 levels | GCST90470060 | 32.97 |
| 183 | Sum neutrophil eosinophil counts | GCST004613 | 32.96 |
| 184 | ATF6 levels | GCST90617260 | 32.96 |
| 185 | MMP9 levels | GCST90469923 | 32.94 |
| 186 | Average diameter for VLDL particles | GCST90093002 | 32.93 |
| 187 | TNFRSF1A/TNFRSF1B ratio | GCST90315937 | 32.82 |
| 188 | High-density lipoprotein levels (MTAG) | GCST90179147 | 32.74 |
| 189 | Concentration of medium HDL particles | GCST90498622 | 32.72 |
| 190 | FOLR2/MSR1 ratio | GCST90314866 | 32.65 |
| 191 | APCS levels | GCST90428463 | 32.63 |
| 192 | LRP1 levels | GCST90469797 | 32.60 |
| 193 | CD163/ICAM1 ratio | GCST90313735 | 32.60 |
| 194 | Neutrophill count | Blood count | UKBB00000497 | 32.54 |
| 195 | PLA2G4A/SDC4 ratio | GCST90315668 | 32.54 |
| 196 | Chronic sputum production | GCST90269902 | 32.47 |
| 197 | Phospholipids in large VLDL | GCST90498247 | 32.46 |
| 198 | EREG/MPIG6B ratio | GCST90314704 | 32.46 |
| 199 | Phospholipids to total lipids ratio in large LDL | GCST90092865 | 32.35 |
| 200 | NTRK2 levels | GCST90470097 | 32.31 |
| 201 | Cholesteryl ester levels in large HDL | GCST90092846 | 32.18 |
| 202 | NUDT5/RWDD1 ratio | GCST90315580 | 32.18 |
| 203 | AXL/MCAM ratio | GCST90313421 | 32.16 |
| 204 | Monounsaturated fatty acid levels | GCST90502362 | 32.15 |
| 205 | Cholesterol levels in large HDL | GCST90092844 | 32.11 |
| 206 | Free cholesterol in medium HDL | GCST90498562 | 32.11 |
| 207 | CFI levels | GCST90468730 | 32.06 |
| 208 | Granulocyte percentage of myeloid white cells | GCST004608 | 31.98 |
| 209 | Phospholipids in very small VLDL | GCST90500840 | 31.97 |
| 210 | ADGRE5/NOTCH1 ratio | GCST90313181 | 31.92 |
| 211 | IGF2R/LGMN ratio | GCST90315131 | 31.80 |
| 212 | Free cholesterol levels in large HDL | GCST90092848 | 31.76 |
| 213 | ENPP2 levels | GCST90469115 | 31.66 |
| 214 | SERPING1 levels | GCST90470600 | 31.63 |
| 215 | CSF3 levels | GCST90468886 | 31.63 |
| 216 | Concentration of large HDL particles | GCST90092851 | 31.61 |
| 217 | Recent worrying too much about different things | Anxiety | UKBB00000746 | 31.60 |
| 218 | TNFRSF8/TNFRSF9 ratio | GCST90315940 | 31.44 |
| 219 | HPGDS levels | GCST90469472 | 31.44 |
| 220 | MSR1 levels | GCST90469950 | 31.41 |
| 221 | CA6 levels | GCST90468515 | 31.38 |
| 222 | Total lipids in medium HDL | GCST90498597 | 31.36 |
| 223 | Triglycerides to Total Lipids in Very Large HDL percentage | GCST90500506 | 31.35 |
| 224 | PLA2G2A levels | GCST90470247 | 31.31 |
| 225 | IDP dMRI TBSS ICVF Cerebral peduncle R | GCST90004341 | 31.23 |
| 226 | CD163/FOLR2 ratio | GCST90313734 | 31.22 |
| 227 | FLT1/TFPI2 ratio | GCST90314856 | 31.18 |
| 228 | IGF2R/RNASET2 ratio | GCST90315132 | 31.15 |
| 229 | Urticaria | GCST90018716 | 31.11 |
| 230 | total creatine kinase (maximum, inv-norm transformed) | GCST90476410 | 30.95 |
| 231 | Cholesteryl Esters to Total Lipids in Medium HDL percentage | GCST90498556 | 30.93 |
| 232 | FKBP4/FKBP5 ratio | GCST90314838 | 30.89 |
| 233 | Cholesterol to Total Lipids in Medium HDL percentage | GCST90498516 | 30.88 |
| 234 | Phospholipids in very small VLDL | GCST90500851 | 30.86 |
| 235 | Total lipid levels in large HDL | GCST90092850 | 30.81 |
| 236 | Osteoporosis, osteopenia and pathological fracture | musculoskeletal | UKBB00000600 | 30.80 |
| 237 | Glycoprotein acetyls levels (UKB data field 23480) | GCST90269577 | 30.79 |
| 238 | GAS6 levels | GCST90469305 | 30.77 |
| 239 | LDLR levels | GCST90469750 | 30.75 |
| 240 | ARSB levels | GCST90468369 | 30.71 |
| 241 | HSPB6/SNCG ratio | GCST90315090 | 30.70 |
| 242 | Sphingomyelins levels | GCST90499983 | 30.58 |
| 243 | CLEC4G/KDR ratio | GCST90314118 | 30.52 |
| 244 | Phospholipids to Total Lipids in Large HDL percentage | GCST90497863 | 30.50 |
| 245 | Phospholipids to Total Lipids in Very Large HDL percentage | GCST90500472 | 30.43 |
| 246 | CCL7 levels | GCST90468585 | 30.32 |
| 247 | MMP9/PLAUR ratio | GCST90315470 | 30.31 |
| 248 | Triglycerides in very large HDL | GCST90500482 | 30.29 |
| 249 | HDL cholesterol levels | GCST90092822 | 30.23 |
| 250 | LAT2/SDC4 ratio | GCST90315278 | 30.22 |
| 251 | COMP levels | GCST90468827 | 30.21 |
| 252 | Phospholipids in HDL | GCST90497437 | 30.12 |
| 253 | CPB2 levels | GCST90468840 | 30.11 |
| 254 | ACY1/GSTA1 ratio | GCST90313163 | 30.05 |
| 255 | ADGRE5/ITGB2 ratio | GCST90313180 | 30.02 |
| 256 | B4GAT1 levels | GCST90468413 | 29.99 |
| 257 | BCAN/MOG ratio | GCST90313480 | 29.94 |
| 258 | Free Cholesterol to Total Lipids in Very Large HDL percentage | GCST90500398 | 29.93 |
| 259 | Free Cholesterol to Total Lipids in Large HDL percentage | GCST90497790 | 29.93 |
| 260 | CASP3/SNAP23 ratio | GCST90313644 | 29.90 |
| 261 | Cholesteryl Esters to Total Lipids in Small HDL percentage | GCST90499406 | 29.81 |
| 262 | Total lipid levels in HDL | GCST90092825 | 29.68 |
| 263 | Free cholesterol levels in HDL | GCST90092824 | 29.61 |
| 264 | Cholesterol to Total Lipids in Large HDL percentage | GCST90497730 | 29.60 |
| 265 | Concentration of small HDL particles | GCST90499464 | 29.60 |
| 266 | DKK1/PTPN6 ratio | GCST90314478 | 29.57 |
| 267 | neutrophil (absolute count, minimum, inv-norm transformed) | GCST90475532 | 29.56 |
| 268 | ADGRE5/VCAM1 ratio | GCST90313184 | 29.54 |
| 269 | Other diseases of blood and blood-forming organs | FING00000998 | 29.37 |
| 270 | Free cholesterol in large HDL | GCST90497786 | 29.33 |
| 271 | Free Cholesterol to Total Lipids in Large HDL percentage | GCST90497793 | 29.32 |
| 272 | Average diameter for VLDL particles | GCST90500290 | 29.21 |
| 273 | SUSD1/THPO ratio | GCST90315899 | 29.21 |
| 274 | CHIT1 levels | GCST90468744 | 29.16 |
| 275 | BTN2A1/SIGLEC1 ratio | GCST90313548 | 29.14 |
| 276 | Average diameter for HDL particles (UKB data field 23433) | GCST90269530 | 29.12 |
| 277 | Cholesteryl Esters to Total Lipids in Large HDL percentage | GCST90497763 | 29.10 |
| 278 | Phospholipid levels in large HDL | GCST90092852 | 29.06 |
| 279 | PEPD levels | GCST90470209 | 29.03 |
| 280 | PDGFB/PTPN6 ratio | GCST90315625 | 29.02 |
| 281 | Cholesterol in large HDL (UKB data field 23561) | GCST90269658 | 28.99 |
| 282 | Cholesterol in Large LDL | GCST90497919 | 28.97 |
| 283 | Cholesteryl esters in large HDL (UKB data field 23562) | GCST90269659 | 28.91 |
| 284 | Phospholipid levels in very large HDL | GCST90093012 | 28.91 |
| 285 | HDL cholesterol levels (UKB data field 23406) | GCST90269503 | 28.82 |
| 286 | HEG1 levels | GCST90469444 | 28.78 |
| 287 | HDL cholesterol | Blood biochemistry | UKBB00000306 | 28.71 |
| 288 | Concentration of very large HDL particles | GCST90500436 | 28.68 |
| 289 | Average diameter for VLDL particles (UKB data field 23431) | GCST90269528 | 28.55 |
| 290 | Cholesterol to Total Lipids in Small HDL percentage | GCST90499373 | 28.52 |
| 291 | Glycoprotein acetyls levels | GCST90497320 | 28.52 |
| 292 | Total protein levels | GCST90018756 | 28.45 |
| 293 | Total lipids in medium HDL | GCST90498604 | 28.45 |
| 294 | monocyte (fraction, maximum, inv-norm transformed) | GCST90475508 | 28.43 |
| 295 | Ratio of triglycerides to phosphoglycerides | GCST90092983 | 28.41 |
| 296 | Total lipid levels in very large HDL | GCST90093010 | 28.38 |
| 297 | FAM20A levels | GCST90469185 | 28.33 |
| 298 | Cholesteryl ester levels in HDL | GCST90092823 | 28.30 |
| 299 | PSG1 levels | GCST90470353 | 28.27 |
| 300 | Average diameter for HDL particles | GCST90497454 | 28.17 |
| 301 | FOLR2 levels | GCST90469260 | 28.15 |
| 302 | MAN1A2 levels | GCST90469843 | 28.13 |
| 303 | Triglyceride to HDL cholesterol ratio | GCST90295949 | 28.12 |
| 304 | Phospholipids in large VLDL (UKB data field 23497) | GCST90269594 | 28.07 |
| 305 | DPP6 levels | GCST90469034 | 27.95 |
| 306 | Concentration of large HDL particles (UKB data field 23558) | GCST90269655 | 27.92 |
| 307 | Triglycerides in small HDL | GCST90499519 | 27.87 |
| 308 | COMP/DPP4 ratio | GCST90314188 | 27.87 |
| 309 | Cake icing liking | GCST90094723 | 27.82 |
| 310 | Monocyte percentage (UKB data field 30190) | GCST90468091 | 27.82 |
| 311 | CD163 levels | GCST90468600 | 27.71 |
| 312 | LAT/PDGFA ratio | GCST90315285 | 27.69 |
| 313 | GALNT7 levels | GCST90469299 | 27.68 |
| 314 | Cholesterol in small HDL (UKB data field 23575) | GCST90269672 | 27.66 |
| 315 | Polyunsaturated fatty acids to monounsaturated fatty acids ratio | GCST90502155 | 27.63 |
| 316 | APOA1 levels | GCST90092808 | 27.63 |
| 317 | PSAP levels | GCST90470351 | 27.60 |
| 318 | Cholesteryl esters in HDL (UKB data field 23418) | GCST90269515 | 27.59 |
| 319 | Triglyceride levels in large VLDL | GCST90092878 | 27.56 |
| 320 | Total lipids in large HDL (UKB data field 23559) | GCST90269656 | 27.50 |
| 321 | PLA2G7 levels | GCST90470249 | 27.46 |
| 322 | Triglycerides in large VLDL (UKB data field 23501) | GCST90269598 | 27.46 |
| 323 | Phospholipids to Total Lipids in Very Large HDL percentage | GCST90500474 | 27.45 |
| 324 | triglyceride (mean, inv-norm transformed) | GCST90476433 | 27.40 |
| 325 | Triglycerides in medium VLDL (UKB data field 23508) | GCST90269605 | 27.39 |
| 326 | Alkenylphosphatidylcholine (P-16:0/16:0) levels | GCST90025563 | 27.33 |
| 327 | Free cholesterol levels in medium HDL | GCST90092896 | 27.25 |
| 328 | Cholesteryl ester levels in very large HDL | GCST90093006 | 27.25 |
| 329 | Concentration of HDL particles | GCST90092826 | 27.23 |
| 330 | Total esterified cholesterol levels | GCST90500036 | 27.21 |
| 331 | Free cholesterol in medium HDL | GCST90498563 | 27.15 |
| 332 | ALCAM/MSR1 ratio | GCST90313240 | 27.15 |
| 333 | High density lipoprotein cholesterol levels | GCST90278635 | 27.03 |
| 334 | Monocyte count | GCST90025950 | 27.00 |
| 335 | Cholesteryl esters in small HDL (UKB data field 23576) | GCST90269673 | 26.98 |
| 336 | APOE levels | GCST90468338 | 26.96 |
| 337 | Cholesterol esters in very large HDL | GCST90500354 | 26.89 |
| 338 | SDC4/SMAD1 ratio | GCST90315820 | 26.86 |
| 339 | Monounsaturated fatty acids to total fatty acids percentage | GCST90502388 | 26.84 |
| 340 | AGRP levels | GCST90012063 | 26.84 |
| 341 | CD300C/NBL1 ratio | GCST90313792 | 26.77 |
| 342 | SKAP2/VSIR ratio | GCST90315849 | 26.74 |
| 343 | CST3/DEFA1_DEFA1B ratio | GCST90314291 | 26.73 |
| 344 | Myeloid white cell count | GCST004626 | 26.72 |
| 345 | CTSO/IGF2R ratio | GCST90314317 | 26.70 |
| 346 | C1QTNF5 levels | GCST90468489 | 26.70 |
| 347 | ADA levels | GCST90468231 | 26.67 |
| 348 | BAIAP2 levels | GCST90468419 | 26.66 |
| 349 | Insomnia (weighted GWA) | GCST90267287 | 26.63 |
| 350 | DMP1 levels | GCST90469007 | 26.62 |
| 351 | IGF2R levels | GCST90469526 | 26.58 |
| 352 | Monocyte count | GCST90002393 | 26.58 |
| 353 | CD163/IL18BP ratio | GCST90313736 | 26.56 |
| 354 | KLK7 levels | GCST90469706 | 26.52 |
| 355 | Concentration of very large HDL particles | GCST90093011 | 26.51 |
| 356 | C-reactive protein levels (UKB data field 30710) | GCST90468064 | 26.41 |
| 357 | CCN2/TPP1 ratio | GCST90313718 | 26.37 |
| 358 | Free cholesterol to total lipids ratio in very large HDL | GCST90093009 | 26.35 |
| 359 | Monocyte percentage of white cells | GCST90002394 | 26.22 |
| 360 | Triglycerides to Total Lipids in Large HDL percentage | GCST90497896 | 26.20 |
| 361 | Concentration of large VLDL particles (UKB data field 23495) | GCST90269592 | 26.15 |
| 362 | VAT1 levels | GCST90471029 | 26.15 |
| 363 | LAT2/MANF ratio | GCST90315277 | 26.11 |
| 364 | Average diameter for VLDL particles | GCST90500279 | 25.99 |
| 365 | Monounsaturated fatty acids to total fatty acids percentage | GCST90502051 | 25.98 |
| 366 | NRCAM levels | GCST90470082 | 25.97 |
| 367 | Total lipids in small HDL (UKB data field 23573) | GCST90269670 | 25.95 |
| 368 | Glycoprotein acetyls levels | GCST90497328 | 25.94 |
| 369 | Free cholesterol to total lipids ratio in chylomicrons and extremely large VLDL | GCST90093045 | 25.90 |
| 370 | Total concentration of lipoprotein particles (UKB data field 23427) | GCST90269524 | 25.88 |
| 371 | Free cholesterol in large HDL (UKB data field 23563) | GCST90269660 | 25.88 |
| 372 | Phosphatidylcholine_40:6_[M+H]1+/Phosphatidylethanolamine_43:6_[M+H]1+ levels | GCST90060446 | 25.84 |
| 373 | Polyunsaturated fatty acids to total fatty acids percentage | GCST90499302 | 25.79 |
| 374 | Free cholesterol in HDL (UKB data field 23422) | GCST90269519 | 25.75 |
| 375 | LCP1 levels | GCST90469748 | 25.74 |
| 376 | Free cholesterol in small HDL (UKB data field 23577) | GCST90269674 | 25.74 |
| 377 | LRG1 levels | GCST90469793 | 25.73 |
| 378 | LTB4R levels | GCST90422164 | 25.72 |
| 379 | Phospholipids in small LDL | GCST90499673 | 25.63 |
| 380 | Total lipids in large VLDL (UKB data field 23496) | GCST90269593 | 25.59 |
| 381 | Triglyceride levels in medium VLDL | GCST90092926 | 25.58 |
| 382 | Concentration of small HDL particles (UKB data field 23572) | GCST90269669 | 25.57 |
| 383 | LILRA2 levels | GCST90469771 | 25.55 |
| 384 | IL6ST/MARCO ratio | GCST90315167 | 25.52 |
| 385 | CCL18/RARRES2 ratio | GCST90313690 | 25.51 |
| 386 | LILRB2 levels | GCST90469777 | 25.49 |
| 387 | T1 FreeSurfer a2009s lh G precentral volume | GCST90384844 | 25.47 |
| 388 | CD207 levels | GCST90468607 | 25.46 |
| 389 | AXL/GAS6 ratio | GCST90313419 | 25.42 |
| 390 | Total lipids in HDL (UKB data field 23426) | GCST90269523 | 25.41 |
| 391 | HDL cholesterol | GCST002223 | 25.39 |
| 392 | FAP/LRRN1 ratio | GCST90314783 | 25.38 |
| 393 | Total lipids in very large HDL | GCST90500410 | 25.32 |
| 394 | White blood cell count | GCST90002374 | 25.29 |
| 395 | DAB2/NCK2 ratio | GCST90314367 | 25.26 |
| 396 | SOD2 levels | GCST90470705 | 25.21 |
| 397 | Phospholipids in small LDL | GCST90499681 | 25.18 |
| 398 | IDP SWI T2star right putamen | GCST90003868 | 25.18 |
| 399 | ITIH3 levels | GCST90469650 | 25.17 |
| 400 | CLEC4A levels | GCST90468771 | 25.16 |
| 401 | Neutrophil count | GCST90025977 | 25.16 |
| 402 | total creatine kinase (mean, inv-norm transformed) | GCST90476413 | 25.15 |
| 403 | LYVE1 levels | GCST90469832 | 25.14 |
| 404 | Cholesterol levels in very large HDL | GCST90093004 | 25.13 |
| 405 | CLEC1B/VSIR ratio | GCST90314106 | 25.13 |
| 406 | Concentration of HDL particles (UKB data field 23430) | GCST90269527 | 25.13 |
| 407 | APOA levels | UKBB00000040 | 25.12 |
| 408 | CD300LG/TNFRSF1A ratio | GCST90313803 | 25.07 |
| 409 | OSM levels | GCST90470133 | 25.07 |
| 410 | Monocyte percentage of white cells | GCST004609 | 25.05 |
| 411 | PINLYP levels | GCST90470238 | 25.02 |
| 412 | Cholesteryl Esters to Total Lipids in Very Large HDL percentage | GCST90500359 | 25.00 |
| 413 | Phospholipids in medium LDL | GCST90498832 | 24.98 |
| 414 | SIGLEC5 levels | GCST90470633 | 24.93 |
| 415 | AXL/VCAM1 ratio | GCST90313423 | 24.93 |
| 416 | Clonal hematopoiesis (large clone) | GCST90102621 | 24.91 |
| 417 | Cholesterol levels in small HDL | GCST90092944 | 24.89 |
| 418 | Osteoporosis NOS | musculoskeletal | UKBB00000599 | 24.88 |
| 419 | Phospholipids in large VLDL | GCST90498243 | 24.88 |
| 420 | Phospholipid levels in large VLDL | GCST90092876 | 24.86 |
| 421 | GSTA1/RBP5 ratio | GCST90314995 | 24.84 |
| 422 | Total cholesterol levels | GCST90500015 | 24.84 |
| 423 | Total concentration of lipoprotein particles | GCST90092990 | 24.82 |
| 424 | Free cholesterol levels in small HDL | GCST90092948 | 24.81 |
| 425 | Cholesteryl ester levels in small HDL | GCST90092946 | 24.80 |
| 426 | NCAM2 levels | GCST90470004 | 24.77 |
| 427 | Concentration of very large VLDL particles (UKB data field 23488) | GCST90269585 | 24.75 |
| 428 | Cholesterol in Medium HDL | GCST90498495 | 24.72 |
| 429 | Dysmenorrheic pain severity | GCST006656 | 24.71 |
| 430 | Phospholipids in IDL | GCST90497626 | 24.69 |
| 431 | Plasma 16a-hydroxy DHEA 3-sulfate levels in chronic kidney disease | GCST90264328 | 24.69 |
| 432 | Free cholesterol in large VLDL (UKB data field 23500) | GCST90269597 | 24.68 |
| 433 | Monocyte count (UKB data field 30130) | GCST90468090 | 24.61 |
| 434 | IDP dMRI TBSS L1 Cingulum cingulate gyrus R | GCST90004109 | 24.60 |
| 435 | Lactosyl-N-nervonoyl-sphingosine (d18:1/24:1) levels | GCST90200098 | 24.56 |
| 436 | CD33 levels | GCST90468625 | 24.48 |
| 437 | GSTA1 levels | GCST90469411 | 24.44 |
| 438 | Osteoporosis | musculoskeletal | UKBB00000598 | 24.42 |
| 439 | Average diameter for LDL particles | GCST90498458 | 24.38 |
| 440 | GFRA2 levels | GCST90469329 | 24.32 |
| 441 | KLK8 levels | GCST90422316 | 24.32 |
| 442 | Benign neoplasm of other and unspecified endocrine glands | FING00000159 | 24.31 |
| 443 | Cholesterol to Total Lipids in Very Large HDL percentage | GCST90500324 | 24.31 |
| 444 | KAZALD1 levels | GCST90469665 | 24.30 |
| 445 | Total fatty acid levels | GCST90502726 | 24.29 |
| 446 | NCS1 levels | GCST90470011 | 24.28 |
| 447 | Neutrophil percentage of white cells | GCST90002399 | 24.23 |
| 448 | LAT/SERPINE1 ratio | GCST90315287 | 24.21 |
| 449 | MAD1L1/POLR2F ratio | GCST90315354 | 24.21 |
| 450 | Linoleic acid to total fatty acids percentage | GCST90498321 | 24.20 |
| 451 | Monocyte percentage | Blood count | UKBB00000480 | 24.20 |
| 452 | Orange juice liking | GCST90094806 | 24.19 |
| 453 | MANF/PDGFB ratio | GCST90315360 | 24.17 |
| 454 | Total lipids in very large HDL | GCST90500423 | 24.06 |
| 455 | Triglyceride levels in very large VLDL | GCST90093026 | 24.05 |
| 456 | Phospholipid levels in HDL | GCST90092827 | 23.98 |
| 457 | Phospholipids in large HDL (UKB data field 23560) | GCST90269657 | 23.94 |
| 458 | HAVCR2/TNFRSF1B ratio | GCST90315030 | 23.90 |
| 459 | Monounsaturated fatty acid levels | GCST90499094 | 23.88 |
| 460 | ADA2 levels | GCST90468215 | 23.86 |
| 461 | Triglycerides to phosphoglycerides ratio (UKB data field 23435) | GCST90269532 | 23.85 |
| 462 | CLEC4M levels | GCST90468775 | 23.81 |
| 463 | Alzheimer's disease | GCST90027158 | 23.78 |
| 464 | white blood cell count (WBC, minimum, inv-norm transformed) | GCST90476457 | 23.76 |
| 465 | Concentration of large VLDL particles | GCST90092875 | 23.72 |
| 466 | KLK8 levels | GCST90425492 | 23.72 |
| 467 | IL6 levels | GCST90469604 | 23.71 |
| 468 | APCS levels | GCST90468328 | 23.70 |
| 469 | Phospholipids to total lipids ratio in IDL | GCST90092840 | 23.68 |
| 470 | neutrophil (absolute count, mean, inv-norm transformed) | GCST90475529 | 23.66 |
| 471 | Monocyte count | GCST004625 | 23.62 |
| 472 | LRRC25 levels | GCST90469801 | 23.60 |
| 473 | MMP12 levels | GCST90469916 | 23.60 |
| 474 | CST3/TAFA5 ratio | GCST90314298 | 23.58 |
| 475 | MARCO/SIGLEC1 ratio | GCST90315387 | 23.56 |
| 476 | CD22/FOLR2 ratio | GCST90313758 | 23.56 |
| 477 | ADIPOQ levels | GCST90468245 | 23.52 |
| 478 | CTSL levels | GCST90012073 | 23.52 |
| 479 | Triglycerides to Total Lipids in Small HDL percentage | GCST90499530 | 23.52 |
| 480 | CD163/SIGLEC1 ratio | GCST90313739 | 23.49 |
| 481 | CD163/MARCO ratio | GCST90313737 | 23.47 |
| 482 | White blood cell count | GCST90002407 | 23.44 |
| 483 | Total lipids in small HDL | GCST90499443 | 23.41 |
| 484 | Triglyceride to phosphoglyceride ratio | GCST90499996 | 23.37 |
| 485 | KLRB1/KLRD1 ratio | GCST90315260 | 23.36 |
| 486 | Phospholipids in medium HDL | GCST90498641 | 23.35 |
| 487 | ARTN levels | GCST90468372 | 23.30 |
| 488 | CLMP/GFRA1 ratio | GCST90314133 | 23.28 |
| 489 | monocyte (absolute count, mean, inv-norm transformed) | GCST90475502 | 23.27 |
| 490 | LGALS8/SOD2 ratio | GCST90315320 | 23.23 |
| 491 | triglyceride (maximum, inv-norm transformed) | GCST90476429 | 23.23 |
| 492 | total creatine kinase (minimum, inv-norm transformed) | GCST90476416 | 23.18 |
| 493 | Docosahexaenoic acid to total fatty acids percentage | GCST90502281 | 23.16 |
| 494 | Total lipid levels in very large VLDL | GCST90093022 | 23.13 |
| 495 | Free cholesterol in very large HDL | GCST90500380 | 23.13 |
| 496 | Inflammatory bowel disease | GCST90432182 | 23.11 |
| 497 | Crohn's disease | GCST90446793 | 23.10 |
| 498 | Phospholipids in very large HDL | GCST90500458 | 23.08 |
| 499 | Free cholesterol levels in chylomicrons and extremely large VLDL | GCST90500975 | 23.05 |
| 500 | Triglycerides in very large HDL | GCST90500481 | 23.05 |
| 501 | APOA1 levels | GCST90468331 | 23.04 |
| 502 | CSF1R levels | GCST90468880 | 23.04 |
| 503 | ERBB3 levels | GCST90469140 | 23.04 |
| 504 | Free cholesterol levels in very large HDL | GCST90093008 | 23.04 |
| 505 | CD163/MSR1 ratio | GCST90313738 | 23.03 |
| 506 | Triglyceride levels in VLDL | GCST90093003 | 23.02 |
| 507 | Androstenediol (3beta,17beta) disulfate (2) levels | GCST90199851 | 23.01 |
| 508 | C-reactive protein | Blood biochemistry | UKBB00000113 | 23.01 |
| 509 | OLR1 levels | GCST90470122 | 23.00 |
| 510 | BCAN levels | GCST90468426 | 22.95 |
| 511 | CCL23 levels | GCST90468575 | 22.94 |
| 512 | LRIG1 levels | GCST90469794 | 22.92 |
| 513 | PDGFRB levels | GCST90470192 | 22.90 |
| 514 | Triglycerides in VLDL (UKB data field 23408) | GCST90269505 | 22.90 |
| 515 | Total lipid levels in large VLDL | GCST90092874 | 22.90 |
| 516 | THPO levels | GCST90470857 | 22.88 |
| 517 | VCAM1 levels | GCST90471031 | 22.88 |
| 518 | Cholesterol levels in very large HDL | GCST90500322 | 22.87 |
| 519 | Macular cyst | FING00000743 | 22.83 |
| 520 | CTSD levels | GCST90468910 | 22.82 |
| 521 | Cholesterol esters in very large HDL | GCST90500344 | 22.80 |
| 522 | Concentration of very large VLDL particles | GCST90093023 | 22.79 |
| 523 | ACAN levels | GCST90468196 | 22.78 |
| 524 | DEFA1_DEFA1B/LCN2 ratio | GCST90314454 | 22.78 |
| 525 | Triglyceride levels in small VLDL | GCST90092978 | 22.77 |
| 526 | PCDH17/THBD ratio | GCST90315607 | 22.76 |
| 527 | Triglycerides to Total Lipids in Large VLDL percentage | GCST90498293 | 22.72 |
| 528 | Phospholipids to Total Lipids in Medium HDL percentage | GCST90498653 | 22.71 |
| 529 | CD59/SCARB2 ratio | GCST90313859 | 22.69 |
| 530 | Phospholipids to total lipids in IDL percentage (UKB data field 23609) | GCST90269706 | 22.68 |
| 531 | IL27 levels | GCST90469060 | 22.67 |
| 532 | IDP SWI T2star left putamen | GCST90003867 | 22.66 |
| 533 | TYRP1 levels | GCST90470998 | 22.65 |
| 534 | Phospholipids to Total Lipids in Medium HDL percentage | GCST90498651 | 22.64 |
| 535 | OLR1/OSM ratio | GCST90315583 | 22.61 |
| 536 | ISM1 levels | GCST90469630 | 22.59 |
| 537 | Total lipids in very large VLDL (UKB data field 23489) | GCST90269586 | 22.59 |
| 538 | TEK levels | GCST90470829 | 22.58 |
| 539 | White blood cell count | GCST004610 | 22.56 |
| 540 | TPP1 levels | GCST90470946 | 22.55 |
| 541 | Concentration of large VLDL particles | GCST90498223 | 22.53 |
| 542 | FHIT/MAX ratio | GCST90314818 | 22.52 |
| 543 | Ulcerative colitis | GCST90446795 | 22.52 |
| 544 | CLSTN2 levels | GCST90468789 | 22.49 |
| 545 | Total lipids in very large VLDL | GCST90500614 | 22.49 |
| 546 | SCARB2 levels | GCST90470535 | 22.47 |
| 547 | CD6/EZR ratio | GCST90313890 | 22.47 |
| 548 | NADK/S100A11 ratio | GCST90315513 | 22.46 |
| 549 | Concentration of very large VLDL particles | GCST90500631 | 22.45 |
| 550 | Fruit juice liking | GCST90094768 | 22.45 |
| 551 | Concentration of small HDL particles | GCST90092951 | 22.45 |
| 552 | Cholesteryl esters in very large HDL (UKB data field 23555) | GCST90269652 | 22.45 |
| 553 | Polyunsaturated fatty acids to monounsaturated fatty acids ratio | GCST90502570 | 22.45 |
| 554 | Total fatty acid levels | GCST90502220 | 22.45 |
| 555 | Blood cell traits latent factor 1 (white cell) | GCST90559243 | 22.44 |
| 556 | Cholesteryl esters to total lipids in large LDL percentage (UKB data field 23616) | GCST90269713 | 22.44 |
| 557 | CTSO levels | GCST90468915 | 22.44 |
| 558 | Follicle stimulating hormone levels | GCST90483476 | 22.34 |
| 559 | Triglyceride levels | GCST90239663 | 22.32 |
| 560 | Cholesterol levels in medium HDL | GCST90092892 | 22.25 |
| 561 | Concentration of medium HDL particles | GCST90092899 | 22.23 |
| 562 | HPCAL1/LAT ratio | GCST90315072 | 22.21 |
| 563 | Triglycerides in large HDL | GCST90497888 | 22.21 |
| 564 | HSD17B14 levels | GCST90469483 | 22.20 |
| 565 | F13B levels | GCST90469167 | 22.18 |
| 566 | IL12B levels | GCST90469549 | 22.14 |
| 567 | FOLR3/KLK8 ratio | GCST90314868 | 22.13 |
| 568 | MAX/STK24 ratio | GCST90315404 | 22.12 |
| 569 | SEZ6L levels | GCST90470607 | 22.07 |
| 570 | Cholesteryl esters to total lipids in small LDL percentage (UKB data field 23626) | GCST90269723 | 22.07 |
| 571 | FCN1 levels | GCST90469203 | 22.06 |
| 572 | Benign neoplasm of eye (PheCode 224) | GCST90475626 | 22.05 |
| 573 | ITGB1/ITGB2 ratio | GCST90315225 | 21.96 |
| 574 | SIGLEC10 levels | GCST90470630 | 21.90 |
| 575 | Monounsaturated fatty acids to total fatty acids percentage | GCST90502389 | 21.86 |
| 576 | GRSF1 levels | GCST90469407 | 21.82 |
| 577 | DPP6/SEZ6L2 ratio | GCST90314543 | 21.81 |
| 578 | LTBP2 levels | GCST90469814 | 21.80 |
| 579 | Phospholipids in very large VLDL (UKB data field 23490) | GCST90269587 | 21.80 |
| 580 | Triglycerides to Total Lipids in Very Large VLDL percentage | GCST90500695 | 21.78 |
| 581 | Total lipids in large VLDL | GCST90498216 | 21.78 |
| 582 | CD248 levels | GCST90468612 | 21.76 |
| 583 | Free cholesterol in medium HDL (UKB data field 23570) | GCST90269667 | 21.76 |
| 584 | PKD1 levels | GCST90470240 | 21.75 |
| 585 | Cholesteryl ester levels in medium HDL | GCST90092894 | 21.75 |
| 586 | ICAM1 levels | GCST90469498 | 21.74 |
| 587 | APOB/APOA1 ratio | GCST90497156 | 21.74 |
| 588 | neutrophil (fraction, mean, inv-norm transformed) | GCST90475538 | 21.69 |
| 589 | Triglyceride levels (UKB data field 30870) | GCST90468106 | 21.68 |
| 590 | LGALS3BP levels | GCST90469760 | 21.66 |
| 591 | Basophill percentage | Blood count | UKBB00000087 | 21.66 |
| 592 | CCL24 levels | GCST90468576 | 21.65 |
| 593 | CCL18 levels | GCST90468570 | 21.64 |
| 594 | Phospholipids to Total Lipids in Large VLDL percentage | GCST90498252 | 21.53 |
| 595 | SIGLEC8 levels | GCST90089886 | 21.49 |
| 596 | IL1RN/LGALS9 ratio | GCST90315160 | 21.43 |
| 597 | RETN/RNASET2 ratio | GCST90315768 | 21.42 |
| 598 | CD164/CD99 ratio | GCST90313740 | 21.38 |
| 599 | Cholesteryl Esters in Medium HDL | GCST90498538 | 21.38 |
| 600 | EREG/GYS1 ratio | GCST90314701 | 21.34 |
| 601 | Generalized epilepsy | FING00000567 | 21.34 |
| 602 | Polyunsaturated fatty acids to monounsaturated fatty acids ratio | GCST90499287 | 21.31 |
| 603 | CD83/TNFRSF4 ratio | GCST90313907 | 21.30 |
| 604 | CD63/CLEC1B ratio | GCST90313863 | 21.29 |
| 605 | Phospholipids in very large HDL (UKB data field 23553) | GCST90269650 | 21.28 |
| 606 | Triglycerides in medium HDL | GCST90498667 | 21.16 |
| 607 | Total lipid levels in lipoprotein particles | GCST90500085 | 21.16 |
| 608 | IL1RL2 levels | GCST90469575 | 21.13 |
| 609 | GP1BA levels | GCST90469380 | 21.12 |
| 610 | Cholesteryl Esters in Large HDL | GCST90497753 | 21.03 |
| 611 | Monocyte count | Blood count | UKBB00000479 | 21.00 |
| 612 | Triglycerides to Total Lipids in Small VLDL percentage | GCST90499922 | 20.98 |
| 613 | NCS1/NPY ratio | GCST90315527 | 20.96 |
| 614 | IDP dMRI ProbtrackX ISOVF fmi | GCST90004536 | 20.96 |
| 615 | APOA1 levels | GCST90269537 | 20.92 |
| 616 | CD5/IL16 ratio | GCST90313861 | 20.90 |
| 617 | Total lipids in very large HDL (UKB data field 23552) | GCST90269649 | 20.89 |
| 618 | CLUL1 levels | GCST90468792 | 20.88 |
| 619 | PDGFA/PLA2G4A ratio | GCST90315615 | 20.85 |
| 620 | Triglycerides to Total Lipids in Large VLDL percentage | GCST90498287 | 20.82 |
| 621 | CCL2/CCL7 ratio | GCST90313696 | 20.82 |
| 622 | Cholesterol levels in chylomicrons and extremely large VLDL | GCST90500918 | 20.81 |
| 623 | CHGA levels | GCST90240699 | 20.79 |
| 624 | Triglycerides to total lipids ratio in small HDL | GCST90092955 | 20.78 |
| 625 | Phospholipids in very large VLDL | GCST90500644 | 20.75 |
| 626 | SIGLEC1 levels | GCST90470632 | 20.74 |
| 627 | RELT/TNFRSF1A ratio | GCST90315767 | 20.73 |
| 628 | CFP levels | GCST90468731 | 20.72 |
| 629 | Triglycerides in very large VLDL (UKB data field 23494) | GCST90269591 | 20.69 |
| 630 | ITGAM/ITGAV ratio | GCST90315209 | 20.65 |
| 631 | HVEM on Terminally Differentiated CD4+ T cell | GCST90001879 | 20.64 |
| 632 | Cholesterol in Small LDL | GCST90499555 | 20.58 |
| 633 | Cholesterol in Large HDL | GCST90497719 | 20.57 |
| 634 | Total lipid levels in medium HDL | GCST90092898 | 20.57 |
| 635 | Cholesterol in Medium LDL | GCST90498703 | 20.56 |
| 636 | Phospholipids to Total Lipids in Very Large VLDL percentage | GCST90500665 | 20.56 |
| 637 | White blood cell (leukocyte) count | Blood count | UKBB00000913 | 20.55 |
| 638 | Cholesterol in medium HDL (UKB data field 23568) | GCST90269665 | 20.52 |
| 639 | Phospholipids in HDL (UKB data field 23414) | GCST90269511 | 20.52 |
| 640 | Free Cholesterol to Total Lipids in Large VLDL percentage | GCST90498204 | 20.51 |
| 641 | THBS4 levels | GCST90470855 | 20.51 |
| 642 | DNAJA2/PRDX5 ratio | GCST90314506 | 20.50 |
| 643 | DCN levels | GCST90468956 | 20.49 |
| 644 | Cholesteryl esters in medium HDL (UKB data field 23569) | GCST90269666 | 20.47 |
| 645 | ADH4/SORD ratio | GCST90313196 | 20.39 |
| 646 | Phospholipid levels in very large VLDL | GCST90093024 | 20.39 |
| 647 | Alzheimer's disease or family history of Alzheimer's disease | GCST90012877 | 20.38 |
| 648 | PLXNB2 levels | GCST90470266 | 20.38 |
| 649 | monocyte (absolute count, maximum, inv-norm transformed) | GCST90475499 | 20.37 |
| 650 | CTSC levels | GCST90468909 | 20.36 |
| 651 | CCL13/CCL17 ratio | GCST90313674 | 20.35 |
| 652 | CD300E/CXCL10 ratio | GCST90313796 | 20.34 |
| 653 | Triglycerides in VLDL | GCST90500304 | 20.32 |
| 654 | PLAUR levels | GCST90470251 | 20.30 |
| 655 | Phospholipids in medium HDL | GCST90498635 | 20.24 |
| 656 | Basophil count | GCST90025997 | 20.23 |
| 657 | PTX3 levels | GCST90470392 | 20.23 |
| 658 | Free cholesterol levels in large VLDL | GCST90092872 | 20.23 |
| 659 | Phospholipids in small HDL (UKB data field 23574) | GCST90269671 | 20.22 |
| 660 | Triglycerides to Total Lipids in Medium VLDL percentage | GCST90499069 | 20.21 |
| 661 | CRIM1/NRP2 ratio | GCST90314261 | 20.18 |
| 662 | CTSZ/HSPG2 ratio | GCST90314318 | 20.17 |
| 663 | Triglyceride levels in large HDL | GCST90092854 | 20.17 |
| 664 | Triglycerides to total lipids in very large HDL percentage (UKB data field 23633) | GCST90269730 | 20.14 |
| 665 | BGN levels | GCST90468441 | 20.11 |
| 666 | Cholesterol in very large HDL (UKB data field 23554) | GCST90269651 | 20.11 |
| 667 | neutrophil (absolute count, maximum, inv-norm transformed) | GCST90475526 | 20.10 |
| 668 | ENPP5 levels | GCST90469116 | 20.07 |
| 669 | IGSF3 levels | GCST90469539 | 20.04 |
| 670 | Cholesterol in large VLDL (UKB data field 23498) | GCST90269595 | 20.04 |
| 671 | PAM levels | GCST90470156 | 19.97 |
| 672 | COL1A1/OMD ratio | GCST90314171 | 19.96 |
| 673 | Triglycerides in large VLDL | GCST90498267 | 19.93 |
| 674 | CDKN1A/TMSB10 ratio | GCST90313978 | 19.91 |
| 675 | ITGA5/LILRA2 ratio | GCST90315204 | 19.91 |
| 676 | Omega-6 fatty acids to total fatty acids percentage | GCST90499210 | 19.91 |
| 677 | ADGRE2 levels | GCST90468237 | 19.91 |
| 678 | ITGB5/SIAE ratio | GCST90315234 | 19.88 |
| 679 | Monounsaturated fatty acid levels | GCST90502363 | 19.88 |
| 680 | Dermatophytosis of nail (PheCode 110.11) | GCST90475562 | 19.88 |
| 681 | Cholesteryl Esters to Total Lipids in Very Large HDL percentage | GCST90500373 | 19.84 |
| 682 | PRCP/SELE ratio | GCST90315726 | 19.81 |
| 683 | Liver condition (ex. cirrhosis) | GCST90475270 | 19.79 |
| 684 | AGR3 levels | GCST90468254 | 19.79 |
| 685 | FIS1/PDGFB ratio | GCST90314830 | 19.77 |
| 686 | CLPP levels | GCST90468785 | 19.77 |
| 687 | White blood cell count | GCST90278647 | 19.76 |
| 688 | Free cholesterol in large VLDL | GCST90498185 | 19.74 |
| 689 | Lifespan | GCST90551885 | 19.73 |
| 690 | ATP5IF1/FIS1 ratio | GCST90313385 | 19.72 |
| 691 | Cholesterol esters in very small VLDL | GCST90500740 | 19.71 |
| 692 | DAPP1/SDC4 ratio | GCST90314399 | 19.71 |
| 693 | Triglyceride to HDL cholesterol ratio | GCST90295951 | 19.66 |
| 694 | Volume of left central nucleus | GCST90474958 | 19.66 |
| 695 | Female infertility, associated with anovulation | FING00000537 | 19.64 |
| 696 | Right-hemisphere dorsal attention network to pallidum white-matter structural connectivity | GCST90302809 | 19.63 |
| 697 | C7 levels | GCST90468502 | 19.61 |
| 698 | Free cholesterol in very large VLDL (UKB data field 23493) | GCST90269590 | 19.59 |
| 699 | Docosahexaenoic acid levels | GCST90501984 | 19.55 |
| 700 | Total lipids in small HDL | GCST90499456 | 19.55 |
| 701 | VNN2 levels | GCST90471044 | 19.53 |
| 702 | Phospholipid levels in medium HDL | GCST90092900 | 19.52 |
| 703 | Triglycerides in very large VLDL | GCST90500671 | 19.52 |
| 704 | FLT4 levels | GCST90469252 | 19.49 |
| 705 | CD163/DSC2 ratio | GCST90313733 | 19.47 |
| 706 | ITGB2 levels | GCST90469644 | 19.43 |
| 707 | PRCP levels | GCST90470314 | 19.43 |
| 708 | Concentration of very large HDL particles (UKB data field 23551) | GCST90269648 | 19.42 |
| 709 | HGF levels | GCST90469449 | 19.42 |
| 710 | BPIFB1 levels | GCST90468462 | 19.42 |
| 711 | Neutrophill percentage (UKB data field 30200) | GCST90468093 | 19.42 |
| 712 | Glycoprotein acetyls levels | GCST90092821 | 19.40 |
| 713 | CD300E levels | GCST90468621 | 19.38 |
| 714 | AIF1 levels | GCST90468267 | 19.38 |
| 715 | CCL18/TFPI ratio | GCST90313691 | 19.38 |
| 716 | S100A11/S100A12 ratio | GCST90315798 | 19.38 |
| 717 | Linoleic acid levels | GCST90092880 | 19.37 |
| 718 | OMG levels | GCST90470124 | 19.37 |
| 719 | GSTA1/PBLD ratio | GCST90314994 | 19.36 |
| 720 | ASPN levels | GCST90468377 | 19.34 |
| 721 | CD300C/MANSC1 ratio | GCST90313791 | 19.33 |
| 722 | MAP4K5/STAMBP ratio | GCST90315382 | 19.32 |
| 723 | NOTCH3/PTPRS ratio | GCST90315547 | 19.32 |
| 724 | Cholesterol to Total Lipids in Very Large HDL percentage | GCST90500333 | 19.29 |
| 725 | Nonspecific chest pain | circulatory system | UKBB00000527 | 19.28 |
| 726 | CRIP2/SNCG ratio | GCST90314262 | 19.28 |
| 727 | CHI3L1/PRSS8 ratio | GCST90314044 | 19.27 |
| 728 | White blood cell count | GCST90025985 | 19.27 |
| 729 | KLK10 levels | GCST90469696 | 19.27 |
| 730 | LAG3/VCAM1 ratio | GCST90315270 | 19.25 |
| 731 | CASP3/PDGFA ratio | GCST90313637 | 19.23 |
| 732 | Free cholesterol to total lipids ratio in medium HDL | GCST90092897 | 19.22 |
| 733 | Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage | GCST90501050 | 19.21 |
| 734 | ADGRG2 levels | GCST90468241 | 19.19 |
| 735 | GFRA1/TNFRSF1A ratio | GCST90314924 | 19.17 |
| 736 | DKK3 levels | GCST90468998 | 19.15 |
| 737 | DNMBP/PTPN1 ratio | GCST90314517 | 19.13 |
| 738 | CLEC4G levels | GCST90468774 | 19.11 |
| 739 | EREG/F2R ratio | GCST90314700 | 19.11 |
| 740 | IL12A or IL12B levels | GCST90469548 | 19.07 |
| 741 | RILP/RWDD1 ratio | GCST90315778 | 19.04 |
| 742 | VIT levels | GCST90471041 | 19.04 |
| 743 | STMN3 levels | GCST90242894 | 19.02 |
| 744 | Low-density lipoprotein levels (MTAG) | GCST90179148 | 19.02 |
| 745 | IDP dMRI TBSS ICVF Posterior thalamic radiation R | GCST90004355 | 19.01 |
| 746 | neutrophil (fraction, maximum, inv-norm transformed) | GCST90475535 | 19.01 |
| 747 | PLA2G15 levels | GCST90470245 | 18.99 |
| 748 | Triglycerides in very small VLDL | GCST90500885 | 18.96 |
| 749 | Cholesteryl esters in chylomicrons and extremely large VLDL (UKB data field 23485) | GCST90269582 | 18.92 |
| 750 | VMO1 levels | GCST90471042 | 18.91 |
| 751 | Total free cholesterol levels | GCST90500063 | 18.91 |
| 752 | NELL2/SEZ6L ratio | GCST90315536 | 18.89 |
| 753 | CLEC5A levels | GCST90468776 | 18.87 |
| 754 | IDP dMRI ProbtrackX ICVF ptr l | GCST90004394 | 18.85 |
| 755 | Total lipids in large VLDL | GCST90498207 | 18.82 |
| 756 | Mucosal proctocolitis | FING00000841 | 18.82 |
| 757 | CFB levels | GCST90468723 | 18.81 |
| 758 | Triglyceride levels in very large HDL | GCST90093014 | 18.81 |
| 759 | IDP dMRI ProbtrackX ISOVF unc l | GCST90004550 | 18.80 |
| 760 | RHOC/TBCB ratio | GCST90315774 | 18.78 |
| 761 | Total triglycerides levels | GCST90092992 | 18.76 |
| 762 | PTP4A3 levels | GCST90470375 | 18.75 |
| 763 | APOD levels | GCST90468337 | 18.73 |
| 764 | CPE levels | GCST90468841 | 18.73 |
| 765 | VSIG4 levels | GCST90471052 | 18.72 |
| 766 | Triglycerides in small VLDL (UKB data field 23515) | GCST90269612 | 18.71 |
| 767 | Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage | GCST90500958 | 18.71 |
| 768 | B4GALT1/IFNGR1 ratio | GCST90313430 | 18.71 |
| 769 | Neutrophil percentage of white cells | GCST004633 | 18.66 |
| 770 | Phospholipids to total lipids in very small VLDL percentage (UKB data field 23604) | GCST90269701 | 18.66 |
| 771 | CTSB levels | GCST90468908 | 18.64 |
| 772 | GALNT10 levels | GCST90469295 | 18.64 |
| 773 | ALB levels | GCST90278616 | 18.63 |
| 774 | TMPRSS15 levels | GCST90470892 | 18.63 |
| 775 | IL12B levels | GCST90274798 | 18.61 |
| 776 | Dermatophytosis (PheCode 110.1) | GCST90475561 | 18.60 |
| 777 | Saturated fatty acids to total fatty acids percentage | GCST90499966 | 18.58 |
| 778 | Free cholesterol to total lipids in medium HDL percentage (UKB data field 23642) | GCST90269739 | 18.56 |
| 779 | FBLN2 levels | GCST90469193 | 18.51 |
| 780 | STK24/TDRKH ratio | GCST90315893 | 18.50 |
| 781 | Phospholipids in large LDL | GCST90498053 | 18.49 |
| 782 | Triglyceride levels in small LDL | GCST90092966 | 18.44 |
| 783 | Triglycerides to Total Lipids in Small HDL percentage | GCST90499543 | 18.41 |
| 784 | CR1 levels | GCST90468851 | 18.41 |
| 785 | Triglycerides to Total Lipids in Very Large VLDL percentage | GCST90500692 | 18.39 |
| 786 | L1CAM levels | GCST90469723 | 18.38 |
| 787 | CFB levels | GCST90240778 | 18.35 |
| 788 | Total Alkenylphosphatidylcholine levels | GCST90025835 | 18.33 |
| 789 | Docosahexaenoic acid to total fatty acids percentage | GCST90497270 | 18.28 |
| 790 | Concentration of medium HDL particles (UKB data field 23565) | GCST90269662 | 18.28 |
| 791 | Triglycerides to total lipids ratio in very large HDL | GCST90093015 | 18.26 |
| 792 | MERTK levels | GCST90469890 | 18.26 |
| 793 | ADGRE1 levels | GCST90468236 | 18.23 |
| 794 | CD5/CD6 ratio | GCST90313860 | 18.22 |
| 795 | CLEC4G/NELL2 ratio | GCST90314122 | 18.22 |
| 796 | Basophil percentage of white cells | GCST90002380 | 18.21 |
| 797 | Cholesterol to total lipids in large HDL percentage (UKB data field 23635) | GCST90269732 | 18.20 |
| 798 | ITGA11 levels | GCST90469633 | 18.19 |
| 799 | CPM/PCSK9 ratio | GCST90314216 | 18.19 |
| 800 | Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage | GCST90500920 | 18.18 |
| 801 | Gestational age at birth (maternal effect) | GCST90268419 | 18.16 |
| 802 | Cholesterol levels in very small VLDL | GCST90500700 | 18.16 |
| 803 | Cholesterol in very large VLDL (UKB data field 23491) | GCST90269588 | 18.14 |
| 804 | DPP4/ITGB1 ratio | GCST90314540 | 18.13 |
| 805 | ADGRE5 levels | GCST90468238 | 18.12 |
| 806 | DTI TBSS L2 Posterior corona radiata L | GCST90384503 | 18.12 |
| 807 | Peptic ulcer (excl. esophageal) | digestive | UKBB00000639 | 18.11 |
| 808 | SF3B4/SIRT2 ratio | GCST90315838 | 18.10 |
| 809 | Dermatophytosis / Dermatomycosis (PheCode 110) | GCST90475560 | 18.07 |
| 810 | DNAJA2/HPCAL1 ratio | GCST90314503 | 18.06 |
| 811 | ITIH3/VCAM1 ratio | GCST90315236 | 18.05 |
| 812 | Phospholipids to Total Lipids in Large VLDL percentage | GCST90498258 | 18.03 |
| 813 | Basophil count | GCST90002379 | 18.03 |
| 814 | Triglycerides to Total Lipids in Small VLDL percentage | GCST90499934 | 18.01 |
| 815 | Total lipid levels in small HDL | GCST90092950 | 18.00 |
| 816 | CXCL14 levels | GCST90468927 | 17.98 |
| 817 | Triglycerides to Total Lipids in Small LDL percentage | GCST90499740 | 17.97 |
| 818 | IDP T1 FAST ROIs R ventral striatum | GCST90002560 | 17.95 |
| 819 | F3/GFRA1 ratio | GCST90314741 | 17.93 |
| 820 | CA4/FOLR2 ratio | GCST90313585 | 17.93 |
| 821 | Takes medication for blood clot/ pulmonary embolism/ deep vein thrombosis (DVT)? | GCST90475210 | 17.92 |
| 822 | Cholesteryl Esters in Large VLDL | GCST90498146 | 17.89 |
| 823 | Phospholipids to total lipids ratio in small LDL | GCST90092965 | 17.89 |
| 824 | Spleen iron concentration | GCST90101831 | 17.88 |
| 825 | Phospholipids to total lipids in large LDL percentage (UKB data field 23614) | GCST90269711 | 17.86 |
| 826 | Cholesteryl esters in very large VLDL (UKB data field 23492) | GCST90269589 | 17.81 |
| 827 | GOLM2 levels | GCST90469376 | 17.81 |
| 828 | Cholesterol to Total Lipids in Medium LDL percentage | GCST90498714 | 17.80 |
| 829 | Free Cholesterol to Total Lipids in Very Large VLDL percentage | GCST90500598 | 17.78 |
| 830 | Mouth/teeth dental problems - Mouth ulcers | Mouth | UKBB00000488 | 17.75 |
| 831 | IL16 levels | GCST90469557 | 17.75 |
| 832 | Docosahexaenoic acid levels | GCST90497256 | 17.73 |
| 833 | Pregnenediol disulfate (C21H34O8S2) levels | GCST90199840 | 17.73 |
| 834 | CCN2/TACC3 ratio | GCST90313717 | 17.70 |
| 835 | Phospholipids to total lipids ratio in very small VLDL | GCST90093037 | 17.69 |
| 836 | Cholesteryl Esters to Total Lipids in Medium LDL percentage | GCST90498747 | 17.69 |
| 837 | EGFLAM levels | GCST90421651 | 17.67 |
| 838 | Cholesteryl Esters in Medium LDL | GCST90498739 | 17.67 |
| 839 | GLB1/IMPA1 ratio | GCST90314932 | 17.66 |
| 840 | PDGFRA levels | GCST90470191 | 17.65 |
| 841 | Any dementia (more control exclusions) | FING00000099 | 17.65 |
| 842 | Total lipids in medium HDL (UKB data field 23566) | GCST90269663 | 17.61 |
| 843 | Triglycerides to Total Lipids in Very Small VLDL percentage | GCST90500886 | 17.61 |
| 844 | Cholesterol to total lipids ratio in large HDL | GCST90092845 | 17.60 |
| 845 | ROBO1 levels | GCST90470489 | 17.57 |
| 846 | Concentration of very large HDL particles | GCST90500431 | 17.57 |
| 847 | Triglycerides to Total Lipids in Medium VLDL percentage | GCST90499073 | 17.57 |
| 848 | Total triglycerides levels | GCST90500126 | 17.55 |
| 849 | ERBB4 levels | GCST90469141 | 17.54 |
| 850 | APOC1 levels | GCST90468336 | 17.54 |
| 851 | aparc-a2009s rh volume G+S-subcentral | GCST90003002 | 17.49 |
| 852 | Free cholesterol to total lipids in very large HDL percentage (UKB data field 23632) | GCST90269729 | 17.49 |
| 853 | Total triglycerides levels (UKB data field 23407) | GCST90269504 | 17.48 |
| 854 | CLEC10A levels | GCST90468763 | 17.47 |
| 855 | Phospholipids to total lipids ratio in large HDL | GCST90092853 | 17.44 |
| 856 | Free cholesterol levels in very large VLDL | GCST90093020 | 17.44 |
| 857 | MPHOSPH8/PSRC1 ratio | GCST90315478 | 17.42 |
| 858 | Triglycerides to Total Lipids in Medium LDL percentage | GCST90498885 | 17.42 |
| 859 | Total protein levels | GCST90025995 | 17.41 |
| 860 | Cholesteryl Esters in Small LDL | GCST90499578 | 17.40 |
| 861 | Docosahexaenoic acid levels | GCST90502255 | 17.39 |
| 862 | IDP dMRI ProbtrackX ICVF ptr r | GCST90004395 | 17.38 |
| 863 | CD300A levels | GCST90468619 | 17.37 |
| 864 | Cholesteryl ester levels in chylomicrons and extremely large VLDL | GCST90093042 | 17.37 |
| 865 | EIF1AX levels | GCST90241120 | 17.36 |
| 866 | METAP2/RILP ratio | GCST90315433 | 17.35 |
| 867 | LDLR/PCSK9 ratio | GCST90315311 | 17.34 |
| 868 | Strawberries liking | GCST90094849 | 17.33 |
| 869 | Benign neoplasm of eye, uveal (PheCode 224.1) | GCST90475629 | 17.30 |
| 870 | Superficial cellulitis and abscess (PheCode 681) | GCST90476165 | 17.30 |
| 871 | EREG levels | GCST90469145 | 17.28 |
| 872 | Free cholesterol to total lipids ratio in large LDL | GCST90092861 | 17.26 |
| 873 | SIGLEC6 levels | GCST90470634 | 17.26 |
| 874 | Total fatty acid levels | GCST90500061 | 17.25 |
| 875 | CEACAM8/MMP9 ratio | GCST90314002 | 17.24 |
| 876 | CXCL10 levels | GCST90274780 | 17.23 |
| 877 | ANXA4/LACTB2 ratio | GCST90313293 | 17.20 |
| 878 | TCN1 levels | GCST90470819 | 17.18 |
| 879 | Other specified diseases of sebaceous glands (PheCode 706.8) | GCST90476215 | 17.15 |
| 880 | WFIKKN2 levels | GCST90471077 | 17.13 |
| 881 | S100A13 levels | GCST90470514 | 17.12 |
| 882 | PMVK/PRDX5 ratio | GCST90315694 | 17.09 |
| 883 | CD300E/EFNA4 ratio | GCST90313797 | 17.08 |
| 884 | Docosahexaenoic acid to total fatty acids percentage | GCST90501997 | 17.07 |
| 885 | ENG/TNFSF10 ratio | GCST90314651 | 17.06 |
| 886 | aseg lh volume Cerebellum-White-Matter | GCST90002618 | 17.05 |
| 887 | TNFSF13 levels | GCST90470921 | 17.04 |
| 888 | Free cholesterol to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23582) | GCST90269679 | 17.03 |
| 889 | CD164/NUDT5 ratio | GCST90313742 | 17.02 |
| 890 | aseg lh intensity Caudate | GCST90003769 | 17.01 |
| 891 | VEGFD levels | GCST90471037 | 16.99 |
| 892 | APLP1 levels | GCST90468330 | 16.99 |
| 893 | Triglycerides x depression interaction (2df test) | GCST90570679 | 16.97 |
| 894 | IFIT2 levels | GCST90090864 | 16.97 |
| 895 | MPIG6B/PDGFB ratio | GCST90315482 | 16.96 |
| 896 | Cholesterol levels in large VLDL | GCST90092868 | 16.96 |
| 897 | Phosphatidylcholine levels | GCST90092937 | 16.94 |
| 898 | Alzheimer's disease (late onset) | GCST002245 | 16.91 |
| 899 | CNST/DOK2 ratio | GCST90314157 | 16.90 |
| 900 | Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage | GCST90500983 | 16.89 |
| 901 | neutrophil (fraction, minimum, inv-norm transformed) | GCST90475541 | 16.88 |
| 902 | CANT1/GSTA1 ratio | GCST90313616 | 16.88 |
| 903 | FURIN levels | GCST90469277 | 16.87 |
| 904 | Other follicular disorders | FING00001050 | 16.86 |
| 905 | Basophil count | GCST90002292 | 16.86 |
| 906 | KLRD1/LY9 ratio | GCST90315261 | 16.85 |
| 907 | MXRA8 levels | GCST90469968 | 16.84 |
| 908 | IDS/SMPDL3A ratio | GCST90315126 | 16.84 |
| 909 | Phospholipids to total lipids in large HDL percentage (UKB data field 23634) | GCST90269731 | 16.82 |
| 910 | Total Lipids in Medium LDL | GCST90498806 | 16.81 |
| 911 | Volume of left central nucleus | GCST90474883 | 16.79 |
| 912 | CCL5/TACC3 ratio | GCST90313707 | 16.78 |
| 913 | PLA2G4A/SPINT2 ratio | GCST90315671 | 16.77 |
| 914 | Sleep duration | Sleep | UKBB00000777 | 16.74 |
| 915 | DAPK2 levels | GCST90468945 | 16.71 |
| 916 | Free cholesterol in medium VLDL | GCST90498965 | 16.68 |
| 917 | FCGR2A/FCGR2B ratio | GCST90314793 | 16.67 |
| 918 | Concentration of chylomicrons and extremely large VLDL particles | GCST90501015 | 16.67 |
| 919 | SORT1/VSIR ratio | GCST90315870 | 16.63 |
| 920 | Concentration of large VLDL particles | GCST90498226 | 16.63 |
| 921 | Total lipids in very large VLDL | GCST90500607 | 16.55 |
| 922 | CD300C/CLEC14A ratio | GCST90313786 | 16.54 |
| 923 | IDP dMRI TBSS ICVF Posterior thalamic radiation L | GCST90004356 | 16.53 |
| 924 | Left-hemisphere control network to accumbens white-matter structural connectivity | GCST90302758 | 16.52 |
| 925 | Phospholipids to Total Lipids in Small HDL percentage | GCST90499494 | 16.51 |
| 926 | MET levels | GCST90469895 | 16.50 |
| 927 | DKK1/MGLL ratio | GCST90314473 | 16.50 |
| 928 | CD300LG/CLEC14A ratio | GCST90313801 | 16.49 |
| 929 | DARS1/USP8 ratio | GCST90314407 | 16.48 |
| 930 | CD200R1/CLEC4G ratio | GCST90313748 | 16.47 |
| 931 | Free cholesterol in very large VLDL | GCST90500575 | 16.47 |
| 932 | FAP levels | GCST90469189 | 16.46 |
| 933 | Cholesteryl Esters in Small LDL | GCST90499586 | 16.45 |
| 934 | PTPN6/SNAP23 ratio | GCST90315747 | 16.39 |
| 935 | EGLN1/LSP1 ratio | GCST90314617 | 16.38 |
| 936 | IDP SWI T2star right pallidum | GCST90003870 | 16.38 |
| 937 | Metabolic syndrome | GCST009602 | 16.34 |
| 938 | ST6GAL1 levels | GCST90470753 | 16.31 |
| 939 | Free cholesterol in medium LDL | GCST90498774 | 16.29 |
| 940 | MANF/SDC4 ratio | GCST90315367 | 16.24 |
| 941 | Concentration of very large VLDL particles | GCST90500628 | 16.23 |
| 942 | RNASET2 levels | GCST90470481 | 16.23 |
| 943 | Triglycerides to Total Lipids in Small LDL percentage | GCST90499726 | 16.22 |
| 944 | Free Cholesterol to Total Lipids in Large VLDL percentage | GCST90498199 | 16.22 |
| 945 | LAG3 levels | GCST90469727 | 16.21 |
| 946 | Cholesterol in chylomicrons and extremely large VLDL (UKB data field 23484) | GCST90269581 | 16.21 |
| 947 | SCLY/SORD ratio | GCST90315816 | 16.20 |
| 948 | Depression (broad) | GCST005902 | 16.20 |
| 949 | Neutrophill percentage | Blood count | UKBB00000498 | 16.20 |
| 950 | ENTPD5 levels | GCST90469121 | 16.20 |
| 951 | QSOX1 levels | GCST90470402 | 16.17 |
| 952 | Total cholines levels | GCST90092812 | 16.17 |
| 953 | ADH4/KYNU ratio | GCST90313193 | 16.16 |
| 954 | DNAJA2/FIS1 ratio | GCST90314501 | 16.14 |
| 955 | Triglycerides in medium VLDL | GCST90499065 | 16.13 |
| 956 | Linoleic acid levels (UKB data field 23449) | GCST90269546 | 16.13 |
| 957 | CD4 levels | GCST90468636 | 16.11 |
| 958 | Phosphoglycerides levels | GCST90092938 | 16.11 |
| 959 | DNAJA2/HCLS1 ratio | GCST90314502 | 16.10 |
| 960 | Phospholipids to Total Lipids in Medium LDL percentage | GCST90498852 | 16.09 |
| 961 | SERPINE1/SMAD1 ratio | GCST90315833 | 16.09 |
| 962 | ERP29 levels | GCST90088843 | 16.07 |
| 963 | Triglycerides to Total Lipids in Medium LDL percentage | GCST90498881 | 16.07 |
| 964 | ACVRL1/SCARB2 ratio | GCST90313157 | 16.05 |
| 965 | CRKL/SERPINB1 ratio | GCST90314272 | 16.05 |
| 966 | Cholesterol in Medium VLDL | GCST90498903 | 16.03 |
| 967 | ITGB6 levels | GCST90469646 | 16.02 |
| 968 | IL6ST/PDGFRA ratio | GCST90315169 | 16.01 |
| 969 | Polyunsaturated fatty acids to monounsaturated fatty acids ratio | GCST90502571 | 15.97 |
| 970 | Alzheimer's disease or family history of Alzheimer's disease | GCST007320 | 15.94 |
| 971 | CD209 levels | GCST90468608 | 15.94 |
| 972 | Triglyceride levels in small HDL | GCST90092954 | 15.94 |
| 973 | HDL x depression interaction (2df test) | GCST90570667 | 15.93 |
| 974 | IDP dMRI TBSS ICVF Posterior limb of internal capsule L | GCST90004346 | 15.92 |
| 975 | AXL levels | GCST90468406 | 15.91 |
| 976 | FCGR2B/NOS3 ratio | GCST90314794 | 15.90 |
| 977 | Squamous cell carcinoma (MTAG) | GCST90137412 | 15.89 |
| 978 | ESM1 levels | GCST90469153 | 15.87 |
| 979 | Cholesterol levels in very large VLDL | GCST90500518 | 15.87 |
| 980 | Monounsaturated fatty acid levels | GCST90092928 | 15.85 |
| 981 | Glycosyl-N-behenoyl-sphingadienine (d18:2/22:0) levels | GCST90200105 | 15.85 |
| 982 | Cholesteryl Esters in Medium VLDL | GCST90498939 | 15.84 |
| 983 | Free cholesterol levels in chylomicrons and extremely large VLDL | GCST90500965 | 15.84 |
| 984 | CRTAM/KLRD1 ratio | GCST90314277 | 15.84 |
| 985 | Osteomyelitis, periostitis, and other infections involving bone (PheCode 710) | GCST90476220 | 15.83 |
| 986 | Saturated fatty acids levels | GCST90502658 | 15.82 |
| 987 | IFNAR1 levels | GCST90469512 | 15.82 |
| 988 | TAX1BP3 levels | GCST90242976 | 15.80 |
| 989 | CFHR2 levels | GCST90468726 | 15.80 |
| 990 | Free cholesterol in very large HDL (UKB data field 23556) | GCST90269653 | 15.79 |
| 991 | Cholesterol levels in very large VLDL | GCST90093016 | 15.79 |
| 992 | IDO1 levels | GCST90469506 | 15.78 |
| 993 | AmygNuclei lh volume Central-nucleus | GCST90002652 | 15.77 |
| 994 | Total lipids in medium VLDL | GCST90499004 | 15.75 |
| 995 | Ulcerative rectosigmoiditis | FING00001394 | 15.75 |
| 996 | SEMA3F levels | GCST90470570 | 15.75 |
| 997 | Allergic rhinitis | GCST90086042 | 15.74 |
| 998 | Phospholipids in medium VLDL | GCST90499024 | 15.73 |
| 999 | STAB2 levels | GCST90470755 | 15.70 |
| 1000 | Physical activity (Total log acceleration 6pm-8pm) | GCST90061418 | 15.70 |